Organigram Global Inc. Common Shares (OGI) Stock Price

OGIStock

$1.22−29.41%52W

Market Cap$171.32M

P/E—

PEG Ratio—

Div yield—

Beta1.59

OGI Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-25.78%

Price vs S&P 500 (4W)26.70%

VGM Score57.74

Book Value / Share (Quarterly)$1.96

P/TBV (Annual)1.26x

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)21.14%

Cash Flow / Share (Quarterly)$-0.01

Price vs S&P 500 (YTD)-39.26%

Gross Margin (TTM)3.77%

Net Profit Margin (TTM)-9.19%

EPS (TTM)$-0.14

10-Day Avg Trading Volume0.18M

EPS Excl Extra (TTM)$-0.14

Revenue Growth (5Y)24.46%

EPS (Annual)$-0.14

ROI (Annual)-5.80%

Gross Margin (Annual)6.64%

Net Profit Margin (5Y Avg)-73.33%

Cash / Share (Quarterly)$0.03

P/E Basic Excl Extra (TTM)11.18x

Revenue Growth QoQ (YoY)-8.85%

ROA (Last FY)-4.40%

Revenue Growth TTM (YoY)41.27%

EBITD / Share (TTM)$-0.10

ROE (5Y Avg)-28.70%

Operating Margin (TTM)-9.84%

Cash Flow / Share (Annual)$-0.13

P/B Ratio0.68x

P/B Ratio (Quarterly)0.68x

Net Income / Employee (Annual)$-15,693

EV / Revenue (TTM)1.12x

Net Interest Coverage (TTM)-0.46x

ROA (TTM)-4.63%

EV / EBITDA (TTM)59.31x

EPS Incl Extra (Annual)$-0.14

Current Ratio (Annual)2.26x

Quick Ratio (Quarterly)1.22x

3-Month Avg Trading Volume0.22M

52-Week Price Return-29.41%

P/E Incl Extra (TTM)11.18x

Revenue / Employee (TTM)$173,556

Tangible BV / Share (Quarterly)$1.75

P/S Ratio (Annual)0.97x

Asset Turnover (Annual)0.46x

52-Week High$2.22

Operating Margin (5Y Avg)-67.17%

EPS Excl Extra (Annual)$-0.14

CapEx CAGR (5Y)-26.35%

Tangible BV CAGR (5Y)0.20%

26-Week Price Return-13.85%

Quick Ratio (Annual)1.18x

13-Week Price Return5.66%

Total Debt / Equity (Annual)0.22x

Current Ratio (Quarterly)2.82x

Enterprise Value$222.01M

Revenue / Share Growth (5Y)0.21%

Asset Turnover (TTM)0.50x

Book Value / Share Growth (5Y)-15.88%

Revenue / Employee (Annual)$164,126

Inventory Turnover (Annual)2.34x

Pretax Margin (Annual)-14.87%

Cash / Share (Annual)$0.16

3-Month Return Std Dev55.33%

Gross Margin (5Y Avg)-10.28%

Net Income / Employee (TTM)$-15,981

ROE (Last FY)-7.09%

Net Interest Coverage (Annual)-0.10x

EPS Basic Excl Extra (Annual)$-0.14

P/FCF (TTM)3.09x

Receivables Turnover (TTM)5.57x

Total Debt / Equity (Quarterly)0.17x

EPS Incl Extra (TTM)$-0.14

Receivables Turnover (Annual)5.39x

ROI (TTM)-5.82%

P/S Ratio (TTM)0.92x

Pretax Margin (5Y Avg)-74.88%

Revenue / Share (Annual)$1.46

Tangible BV / Share (Annual)$1.61

Forward P/E23.96x

Price vs S&P 500 (52W)-47.97%

P/E Ratio (TTM)11.18x

Year-to-Date Return-27.27%

5-Day Price Return-3.45%

EPS Normalized (Annual)$-0.14

ROA (5Y Avg)-24.98%

Net Profit Margin (Annual)-9.55%

Month-to-Date Return28.24%

Cash Flow / Share (TTM)$-1.82

EBITD / Share (Annual)$-0.08

Operating Margin (Annual)-8.44%

LT Debt / Equity (Annual)0.20x

P/CF (TTM)24.93x

ROI (5Y Avg)-27.78%

P/E Excl Extra (TTM)11.18x

LT Debt / Equity (Quarterly)0.14x

EPS Basic Excl Extra (TTM)$-0.14

P/TBV (Quarterly)0.76x

P/B Ratio (Annual)1.08x

Inventory Turnover (TTM)2.11x

Pretax Margin (TTM)-14.18%

Book Value / Share (Annual)$1.87

Price vs S&P 500 (13W)3.71%

Beta1.59x

Revenue / Share (TTM)$1.50

ROE (TTM)-6.83%

52-Week Low$0.86

vGradeB

gGradeB

mGradeC

vgmGradeC

OGI Earnings Surprise History

Quarter	Report date	EPS estimate	EPS actual	Surprise
Q2 2026	Aug 11, 2026	-$0.00	$0.40	+23906.01%(+$0.40)
Q4 2025	Feb 10, 2026	-$0.01	-$0.01	-79.43%(-$0.00)
Q3 2025	Dec 16, 2025	-$0.01	-$0.15	-2836.57%(-$0.14)
Q2 2025	Aug 13, 2025	-$0.01	-$0.00	+59.50%(+$0.01)

OGI Analyst Recommendations

May 2026

Jun 2026

Jul 2026

Aug 2026

3.89

Industry Peers — Pharmaceuticals(570)

Symbol	Value Score	Growth Score	Momentum Score	Price
OGIOrganigram Global Inc. Common Shares	B	B	C	$1.22
LLYEli Lilly & Co.	D	B	C	$1174.61
JNJJohnson & Johnson	D	C	B	$268.04
ABBVABBVIE INC.	D	C	B	$255.48
MRKMerck & Co., Inc.	D	C	B	$148.35
NVSNovartis AG	C	C	C	$153.81
AZNAstraZeneca PLC	C	B	C	$162.70
NVONovo-Nordisk A/S	B	C	C	$45.61
ABTAbbott Laboratories	C	C	C	$112.47
PFEPfizer Inc.	C	D	B	$27.96
VRTXVertex Pharmaceuticals Inc	D	C	B	$541.69
BMYBristol-Myers Squibb Co.	B	B	B	$66.58
SNYSanofi American Depositary Shares (Each representing one-half of one ordinary share)	B	C	C	$44.82
GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares)	B	C	C	$50.82
REGNRegeneron Pharmaceuticals Inc	C	C	B	$794.19
TAKTakeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)	C	C	B	$18.03
TEVATeva Pharmaceutical Industries Limited American Depositary Shares	C	C	C	$36.44
ONCBeOne Medicines Ltd. American Depositary Shares	D	B	B	$366.73
RPRXRoyalty Pharma plc Class A Ordinary Shares	D	D	B	$60.85
ZTSZOETIS INC.	C	C	D	$77.34
ALNYAlnylam Pharmaceuticals, Inc.	D	A	D	$237.10
INSMInsmed, Inc.	F	A	C	$118.54
ROIVRoivant Sciences Ltd. Common Shares	D	F	B	$34.71
UTHRUnited Therapeutics Corp	C	C	B	$515.46
GMABGenmab A/S ADS	C	C	B	$33.23
VTRSViatris Inc. Common Stock	B	C	B	$16.34
ASNDAscendis Pharma A/S Ordinary Share	D	A	C	$247.91
JAZZJazz Pharmaceuticals, Inc.	B	C	B	$244.54
BBIOBridgeBio Pharma, Inc. Common Stock	F	A	B	$76.60
BMRNBioMarin Pharmaceuticals Inc	C	C	B	$64.67
MDGLMadrigal Pharmaceuticals, Inc. Common Stock	D	A	B	$533.76
CORTCorcept Therapeutics Inc.	F	C	B	$113.88
ELANElanco Animal Health Incorporated Common Stock	C	B	C	$24.11
ARWRArrowhead Research Corporation	D	A	B	$84.91
SMMTSummit Therapeutics Inc. Common Stock	F	—	D	$13.73
AXSMAxsome Therapeutics, Inc	D	B	C	$199.02
RDYDr. Reddy's Laboratories Limited American Depositary Shares	D	D	C	$12.18
IONSIonis Pharmaceuticals, Inc. Common Stock	D	D	C	$61.05
CYTKCytokinetics Inc.	F	D	C	$72.09
ABVXAbivax SA American Depositary Shares	—	—	C	$113.35
NUVLNuvalent, Inc. Class A Common Stock	—	—	B	$123.96
PRAXPraxis Precision Medicines, Inc. Common Stock	F	—	B	$344.75
PTGXProtagonist Therapeutics, Inc	F	B	B	$144.33
CRNXCrinetics Pharmaceuticals, Inc.	F	A	A	$84.84
TGTXTG Therapeutics, Inc.	D	B	B	$53.93
SYRESpyre Therapeutics, Inc. Common Stock	—	—	B	$90.36
ALKSAlkermes Inc. plc	D	C	B	$47.41
RYTMRhythm Pharmaceuticals, Inc. Common Stock	F	B	C	$107.17
ERASErasca, Inc. Common Stock	—	—	A	$18.03
TVTXTravere Therapeutics, Inc. Common Stock	F	B	A	$65.67
BLTEBelite Bio, Inc American Depositary Shares	—	—	C	$151.72

About Organigram Global Inc. Common Shares

Organigram Global Inc is a licensed cannabis cultivator and manufacturer focused on Canada's adult recreational market, operating production facilities in Moncton, New Brunswick, Lac-Supérieur, Quebec, and a dedicated edibles facility in Winnipeg, Manitoba. The company maintains a diversified brand portfolio including Edison, SHRED, Monjour, and multiple other consumer-facing brands across cannabis and cannabis-derived products.